Joel Iff

Joel Iff is a seasoned professional in health economics and market access, currently serving as Senior Director Global HEOR at Vertex Pharmaceuticals since September 2025. Prior to this role, Joel held multiple senior positions at Sarepta Therapeutics from March 2018 to September 2025, including Executive Director of Global Access, Value & Evidence, and Senior Director of HEOR & Market Access. Notable contributions also include serving as a Steering Committee Company Representative for cTAP-duchenne from June 2020 to June 2024, where strategic leadership and alignment among stakeholders were key responsibilities. Joel's previous experience encompasses roles at Mapi Group, Johnson & Johnson, Synthes, and sanofi-aventis. Joel holds a Diploma in Health Economics from the University of York and a Doctorate in Pharmaceutical Sciences from the University of Geneva.